Cyto-Facto Inc.
PrivateLast Round
Series B
Jun 13, 2025
Total Funding Raised
$18M
Company Overview
Cyto-Facto Inc. is a biotechnology company that provides contract development and manufacturing (CDMO) services for gene and cell therapy solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Precision Medicine, Smart Manufacturing, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyto-Facto Inc. Comps
Public and private peers based on sector, stage, and business model.
Cyto-Facto Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 13, 2025 | ||||
| Series A | Apr 22, 2024 | ||||
| Seed | Aug 28, 2023 |
Cyto-Facto Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kobe University Capital | Series A |
| Mizuho Capital | Series A |
| MPower Partners | Series B, Series A |
| Sumitomo Corporation | Series B |
| Mitsubishi Corporation | Series A |
| SMBC Venture Capital | Series A |
| Fujifilm Corporation | Series B |
Cyto-Facto Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cyto-Facto Inc.'s valuation, stock price, and market status.
